Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 100 500 points on Thursday. The Dow ...

Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering ...

Dogecoin (DOGE), the memecoin known for its Shiba Inu mascot, has witnessed a significant increase in network activity. Over ...

Long AXP: strong momentum and upward price targets indicate continued bullish run toward $300 ...

The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...

Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with ...

Vivos Therapeutics shares surged 47.50% to close at $4.13, after hitting an intraday high of $5.95 and a low of $3.02. The ...

On Wednesday, Vivos Therapeutics Inc (VVOS) stock saw a modest uptick, ending the day at $4.13 which represents a slight increase of $1.33 or 47.50% from the prior close of $2.8. The stock opened at ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Charting, Price Performance, News & Related Contracts.

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...